Arrotex gains exclusive rights in Australia and New Zealand to innovative single pill combination of three hypertension ...

Chronos‑PD shows that biological changes associated with Parkinson’s disease (PD) can emerge up to 12 years before clinical diagnosisUncovered reproducible early molecular signals and distinct ...

A new aligned pathway between the Medicines and Healthcare products Regulatory Agency (MHRA) and NICE, along with an improved advice service, will help bring medicines to patients faster and give ...

You may think heart disease is a “middle age” problem. The research suggests men’s risk increases much earlier than most ...

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

Discover how therapeutic peptides act as biological messengers to treat disease, improve metabolism, and enhance immune ...

A clinical trial suggests that a wake-promoting drug may help early-morning shift workers overcome the biological challenges of working during hours when the brain expects sleep.

Rising diagnoses of young onset dementia highlight the need for early recognition and timely evaluation of a condition that disrupts patients’ careers, families, and financial stability.

In MS trials, investigators are steering those cells toward B‑cell populations that appear to be driving inflammation.

By Anirban Sen NEW YORK, March 11 (Reuters) - Braidwell, an investment firm that was launched by former Deerfield Management executive Alex Karnal and former Bridgewater Associates COO Brian Kreiter, ...

Understanding the type of arthritis, its causes, and management options is the first step toward living well with the condition.